AstraZeneca’s Gout Treatment OK, But Post-Marketing Studies Needed
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA's Arthritis Drugs Advisory Committee recommends approval of lesinurad despite concerns about safety.